Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine + Propranolol for First Bleed Prevention in Decompensated Cirrhosis
NCT04208776Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of midodrine in decompensated cirrhosis (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Primary prevention of first variceal bleed at 1 year. Started Feb 2020; status: completed.
02
Drugs
midodrine
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT04208776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208776.